Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charlie Hospital Semarang Tbk. (RSCH) vs Saraswanti Indoland Development Tbk. (SWID) Price & Performance

Charlie Hospital Semarang Tbk.Trade
Saraswanti Indoland Development Tbk.Trade

Price performance (Past 24H)

Key statistics

Charlie Hospital Semarang Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp92 (market cap 490.04B, 1.51M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is the larger of the two by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 1.51M). Which is the better fit depends on your goals.

RSCHSWID
Market Cap
742B490.04B
Volume
29.45M1.51M
Lot
294.49K15.14K
Turnover
8.14B137.63M
Average Price
276.3590.94
Value
8.14B137.63M
Indicative Equilibrium Price
27092
Indicative Equilibrium Volume
1031.49K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RSCH
View details
SWID
View details

About Charlie Hospital Semarang Tbk.

PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.

Read more on RSCH

About Saraswanti Indoland Development Tbk.

PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.

Read more on SWID